Serina Therapeutics, Inc. — Director's Dealing 2020

Jun 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AgeX Therapeutics, Inc. (AGE)
CIK: 0001708599
Period of Report: 2020-05-15

Reporting Person: Juvenescence Ltd (10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-15	Warrant to Purchase Common Stock	$0.7	P	714285	Acquired	2023-05-14	Common Stock (714285)	Direct
2020-06-11	Warrant to Purchase Common Stock	$0.924	P	541125	Acquired	2023-06-10	Common Stock (541125)	Direct

Footnotes

F1: Issued in connection with Loan Facility Agreement.

F2: Warrant shares are exercisable as of the date of issuance of the warrant.